Largest Pharmaceutical Stocks
The biggest pharmaceutical preparation companies, with dividend yields where paid.
| # | Company | Price | Change | Dividend Yield | Market Cap |
|---|---|---|---|---|---|
| 1 | LLYEli Lilly & Co. | $1184.83 | ▲ 0.12% | 0.58% | $1.05 trillion |
| 2 | JNJJohnson & Johnson | $272.30 | ▲ 0.40% | 1.97% | $653.61 billion |
| 3 | ABBVABBVIE INC. | $266.28 | ▲ 0.73% | 2.60% | $467.12 billion |
| 4 | ABTAbbott Laboratories | $101.29 | ▲ 0.22% | 2.49% | $175.27 billion |
| 5 | PFEPfizer Inc. | $28.67 | ▲ 0.92% | 6.00% | $163.41 billion |
| 6 | BMYBristol-Myers Squibb Co. | $62.86 | ▲ 2.21% | 4.01% | $128.41 billion |
| 7 | ALNYAlnylam Pharmaceuticals, Inc. | $255.96 | ▲ 2.55% | — | $34.25 billion |
| 8 | INSMInsmed, Inc. | $129.41 | ▲ 1.67% | — | $28.26 billion |
| 9 | RPRXRoyalty Pharma plc Class A Ordinary Shares | $57.99 | ▼ 0.51% | 1.62% | $25.96 billion |
| 10 | ROIVRoivant Sciences Ltd. Common Shares | $35.80 | ▼ 0.91% | — | $25.86 billion |
| 11 | VTRSViatris Inc. Common Stock | $18.27 | ▲ 2.47% | 2.63% | $20.48 billion |
| 12 | CORTCorcept Therapeutics Inc. | $116.10 | ▼ 2.03% | — | $12.55 billion |
| 13 | SMMTSummit Therapeutics Inc. Common Stock | $15.48 | ▼ 0.83% | — | $12.45 billion |
| 14 | BMRNBioMarin Pharmaceuticals Inc | $59.35 | ▼ 1.50% | — | $11.66 billion |
| 15 | ELANElanco Animal Health Incorporated Common Stock | $22.30 | ▼ 0.20% | — | $11.17 billion |
| 16 | PRAXPraxis Precision Medicines, Inc. Common Stock | $334.58 | ▼ 1.18% | — | $9.34 billion |
| 17 | PTGXProtagonist Therapeutics, Inc | $140.90 | ▼ 0.68% | — | $9.18 billion |
| 18 | TGTXTG Therapeutics, Inc. | $57.43 | ▼ 0.16% | — | $8.79 billion |
| 19 | SYRESpyre Therapeutics, Inc. Common Stock | $85.69 | ▼ 1.61% | — | $7.56 billion |
| 20 | AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | $19.77 | ▼ 0.18% | — | $6.89 billion |
| 21 | RYTMRhythm Pharmaceuticals, Inc. Common Stock | $98.66 | ▲ 0.36% | — | $6.79 billion |
| 22 | KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $75.08 | ▼ 0.35% | — | $5.86 billion |
| 23 | MIRMMirum Pharmaceuticals, Inc. Common Stock | $86.74 | ▼ 3.30% | — | $5.82 billion |
| 24 | TVTXTravere Therapeutics, Inc. Common Stock | $59.26 | ▼ 2.24% | — | $5.71 billion |
| 25 | PTCTPTC Therapeutics, Inc. | $65.95 | ▲ 5.23% | — | $5.23 billion |
| 26 | VKTXViking Therapeutics, Inc | $35.56 | ▼ 3.24% | — | $4.43 billion |
| 27 | TNGXTango Therapeutics, Inc. | $24.30 | ▼ 2.49% | — | $4.20 billion |
| 28 | ABCLAbCellera Biologics Inc. Common Shares | $12.70 | ▲ 0.40% | — | $4.12 billion |
| 29 | AMLXAmylyx Pharmaceuticals, Inc. Common Stock | $30.04 | ▲ 1.87% | 5.59% | $3.76 billion |
| 30 | XENEXenon Pharmaceuticals Inc | $36.94 | ▼ 2.94% | — | $3.58 billion |
| 31 | ACADAcadia Pharmaceuticals Inc. | $20.68 | ▼ 6.76% | — | $3.56 billion |
| 32 | IDYAIDEAYA Biosciences, Inc. Common Stock | $36.69 | ▼ 0.14% | — | $3.54 billion |
| 33 | ARQTArcutis Biotherapeutics, Inc. Common Stock | $24.25 | ▲ 1.53% | — | $3.00 billion |
| 34 | DYNDyne Therapeutics, Inc. Common Stock | $16.03 | ▼ 2.91% | — | $2.99 billion |
| 35 | ZLABZai Lab Limited American Depositary Shares | $24.98 | ▼ 1.19% | — | $2.80 billion |
| 36 | PGENPrecigen, Inc. Common Stock | $7.75 | ▲ 0.65% | — | $2.77 billion |
| 37 | NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares | $22.58 | ▼ 0.70% | — | $2.70 billion |
| 38 | QUREuniQure N.V. | $38.01 | ▼ 0.81% | — | $2.66 billion |
| 39 | GPCRStructure Therapeutics Inc. American Depositary Shares | $35.93 | ▼ 0.25% | — | $2.56 billion |
| 40 | SLSSELLAS Life Sciences Group, Inc. Common Stock | $11.72 | ▲ 1.56% | 8.20% | $2.33 billion |
| 41 | VRDNViridian Therapeutics, Inc. Common Stock | $20.64 | ▲ 0.83% | — | $2.32 billion |
| 42 | MLYSMineralys Therapeutics, Inc. Common Stock | $25.86 | ▼ 2.75% | — | $2.29 billion |
| 43 | TRVITrevi Therapeutics, Inc. Common Stock | $15.90 | ▼ 0.06% | — | $2.27 billion |
| 44 | PBHPrestige Consumer Healthcare Inc. | $46.61 | ▲ 2.10% | — | $2.21 billion |
| 45 | AUPHAurinia Pharmaceuticals Inc | $16.57 | ▲ 0.76% | — | $2.19 billion |
| 46 | SDGRSchrodinger, Inc. Common Stock | $28.85 | ▼ 2.04% | — | $2.16 billion |
| 47 | BHVNBiohaven Ltd. | $14.89 | ▲ 4.71% | — | $2.15 billion |
| 48 | PRGOPERRIGO COMPANY PLC | $15.42 | ▲ 5.04% | 7.52% | $2.14 billion |
| 49 | BHCBausch Health Companies Inc | $5.69 | ▲ 0.71% | — | $2.13 billion |
| 50 | NKTRNektar Therapeutics | $58.85 | ▼ 0.89% | — | $2.03 billion |
Rankings reflect our cached coverage universe and delayed fundamental data. For informational purposes only — not investment advice.